In the BioHarmony Drug Report Database

"Preview" Icon

Nicotine polacrilex

Nicorette, Nicorette (mint) (nicotine polacrilex) is a small molecule pharmaceutical. Nicotine polacrilex was first approved as Nicorette on 1996-02-09. It is used to treat tobacco use disorder and ulcerative colitis in the USA. It is known to target neuronal acetylcholine receptor subunit alpha-4, neuronal acetylcholine receptor subunit alpha-9, neuronal acetylcholine receptor subunit alpha-10, potassium voltage-gated channel subfamily D member 3, neuronal acetylcholine receptor subunit alpha-3, and transient receptor potential cation channel subfamily A member 1. Rugby nicotine polacrilex gum, mint flavor’s patents are valid until 2029-06-14 (FDA).

 

Trade Name

 

Nicorette, Nicorette (mint)
 

Common Name

 

nicotine polacrilex
 

ChEMBL ID

 

CHEMBL1201536
 

Indication

 

tobacco use disorder, ulcerative colitis
 

Drug Class

 

Image (chem structure or protein)

Nicotine polacrilex structure rendering